Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05283798
Other study ID # intra cs IUD
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 2022
Est. completion date December 2023

Study information

Verified date October 2021
Source Assiut University
Contact Mahmoud Abdelhameed
Phone 01096128561
Email m7moud3bdel7ameed@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare efficacy safety & side effects of multiload 375 IUD versus copper T 380 IUD when inserted during elective CS


Description:

Insertion of an intrauterine device (IUD) immediately after delivery is appealing for several reasons. The woman is known not to be pregnant, her motivation for contraception may be high, and the setting may be convenient for both the woman and her provider The World Health Organization (WHO) recommends that a woman should wait at least 24 months after delivery before the next pregnancy to decrease the adverse maternal, perinatal ,and infant outcomes. Compared with other contraceptive methods, early post-partum IUD insertion has several advantages. It provides immediate contraception without interfering with breast feeding, and it may avoid discomfort related to insertion. Inserting an IUD immediately after placental removal has not been associated with increased infection, uterine perforation, postpartum bleeding, or uterine subinvolution . The expulsion rate is higher (approximately 12% in the first postpartum year) after immediate postpartum insertion compared to insertion 4 to 8 weeks later. Continuation rates are relatively high (87.6% and 76.3%, at 6 and 12 months, respectively Studies have shown that with effective provider training, the immediate postpartum IUD insertion (IPPIUD) complications such as expulsion, pelvic infection, bleeding, pain, missing threads ,and failure rates are not significantly different from those of interval PPIUD insertion (4:6 weeks) after delivery


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 300
Est. completion date December 2023
Est. primary completion date December 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: women delivered by elective CS = 36 wks Exclusion Criteria: Patients with PROM Patients on corticosteroids therapy Patients on anticoagulant patients who refuse participate in the study with written consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
IUD
Postpartum intra-caesarean section insertion of copper T380 versus multiload 375

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mahmoud Abdelhameed Hussien Soliman

Outcome

Type Measure Description Time frame Safety issue
Primary expulsion rate after 6 weeks of insertion compare expulsion rates between the two types after 6 weeks by ultrasoud 6 weeks
Secondary compare bleedind dayes and shift to anthor methoud - number of bleeding days in the 1st 6 weeks
- number of bleeding days in each month in the 1st 6 months
compare by US between the 2 types
- the shift into another method and what is it
6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03868137 - Multi-dose Ibuprofen Prophylaxis for IUD-insertion N/A
Completed NCT04539899 - Evaluation of the Influence of the Virtual Reality Helmet on Pain During IUD Insertion N/A
Recruiting NCT06023849 - Trans Caesarean Intra Uterine Contraceptive Device Insertion Versus Conventional Postpartum 6 Weeks Insertion N/A
Completed NCT04932382 - Misoprostol Prior to Intrauterine Device Insertion N/A
Active, not recruiting NCT04927741 - Essential Oils Following IUD Insertion N/A
Completed NCT05383924 - Intrauterine Contraceptive Device Insertion During Cesarean Section (CS) Versus Delayed Insertion N/A
Completed NCT04389021 - Virtual Reality Simulation for Intrauterine Device Insertion: A Randomized Clinical Trial N/A
Completed NCT05187078 - Allis Clamp Versus Single-tooth Tenaculum N/A
Recruiting NCT05339555 - IUD Self-Removal Study N/A
Completed NCT04379102 - The Role Of Local Anesthetics in the Management of Adverse Effects Associated With Intrauterine Device Application
Recruiting NCT05875571 - Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement Phase 4
Active, not recruiting NCT02076217 - Quick Start of Highly Effective Contraception
Recruiting NCT05700812 - IUD Placement Without Sounding N/A
Recruiting NCT05252117 - Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research. Phase 4
Not yet recruiting NCT05471362 - Barriers of Immediate Postpartum Intrauterine Device Uptake
Not yet recruiting NCT04630548 - Safety and Efficacy of Immediate Post Placental IUD Insertion in Patients Undergoing Cesarean Delivery N/A
Not yet recruiting NCT06240260 - TENS Unit for Analgesia During IUD Insertion N/A
Completed NCT06042556 - IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings N/A